The
slide to be stained for PR comprised the following five tissues:
| No. |
Tissue |
PR-positivity* |
PR-intensity* |
| 1. |
Uterine cervix |
80-90% |
Moderate to strong |
| 2. |
Breast ductal carcinoma |
Negative |
Negative |
| 3. |
Breast ductal carcinoma |
30-50% |
Weak to moderate |
| 4. |
Breast ductal carcinoma |
50-70% |
Moderate to strong |
| 5. |
Breast ductal carcinoma |
90-100% |
Strong |
*PR status and staining
pattern (using mAb clone PgR 636 and rmAb clone 1E2) as assessed by
by two reference laboratories.
All tissues were fixed in 10% neutral buffered formalin for 24 – 48
hours according to consensus recommendations.1
Criteria for assessing a PR staining as optimal included:
- A moderate to strong, distinct nuclear
staining of the columnar epithelial cells, the basal squamous
epithelial cells and most of the stromal cells (with the
exception of endothelial cells and lymphoid cells) in the
uterine cervix.
- A moderate to strong, distinct nuclear
staining of the ductal breast carcinomas no. 3, 4 & 5 in
accordance with the PR status.
- No nuclear staining of the PR negative
ductal breast carcinoma no. 2 – only epithelial cells in
remnants of normal glands should show a positive reaction.
177 laboratories participated in this
assessment. 77% achieved a sufficient mark. In table 1 the
antibodies (Abs) used and marks are summarized.
Table 1.
Abs and
assessment marks
for PR, run B9
|
Concentrated Abs |
N |
Vendor |
Optimal |
Good |
Borderl. |
Poor |
Suff.1 |
Suff. OPS2 |
|
mAb clone PgR 636 |
61 |
Dako |
32 |
14 |
2 |
13 |
75% |
87% |
|
mAb clone 16 |
22
1
1 |
Novocastra
Monosan
Vector |
18 |
2 |
2 |
2 |
83% |
86% |
|
mAb clone 1A6 |
3
1 |
Novocastra
BioGenex |
0 |
2 |
2 |
0 |
- |
- |
|
mAb clone PgR 1294 |
2 |
Dako |
0 |
2 |
0 |
0 |
- |
- |
|
mAb clone PR88 |
2 |
BioGenex |
0 |
1 |
0 |
1 |
- |
- |
|
mAb clone PR-1 |
2 |
Immunovision |
0 |
0 |
0 |
2 |
- |
- |
mAb clone cocktail
16+SAN27 |
2 |
Novocastra |
1 |
0 |
0 |
1 |
- |
- |
|
rmAb clone SP2 |
7 |
NeoMarkers |
2 |
0 |
0 |
5 |
40% |
50% |
|
rmAb clone Y85 |
1 |
Master Diagnostica |
0 |
0 |
1 |
0 |
- |
- |
|
Unknown |
1 |
Unknown |
0 |
1 |
0 |
0 |
- |
- |
|
Ready-To-Use Abs |
|
|
|
|
|
|
|
|
mAb clone
PgR 636, IR068 |
12 |
Dako |
11 |
1 |
0 |
0 |
100% |
100% |
mAb clone
PgR 636, N1630 |
2 |
Dako |
0 |
0 |
2 |
0 |
- |
- |
mAb clone
PgR 636, PM343 |
1 |
Biocare |
0 |
1 |
0 |
0 |
- |
- |
|
mAb clone PgR 1294, SK310/K1904/K4071 |
5 |
Dako |
2 |
2 |
0 |
1 |
- |
- |
|
mAb clone 16, PA0312 |
1 |
Leica |
1 |
0 |
0 |
0 |
- |
- |
|
rmAb clone 1E2, 790-2223/790-4296 |
47 |
Ventana/Cell Marque |
35 |
8 |
2 |
2 |
91% |
93% |
|
rmAb clone
SP2, RM-9102-R7 |
2 |
NeoMarkers |
0 |
0 |
0 |
2 |
- |
- |
|
rmAb clone
SP2, ZA0255 |
1 |
Unknown |
0 |
0 |
0 |
1 |
- |
- |
|
Total |
177 |
|
102 |
34 |
11 |
30 |
- |
- |
|
Proportion |
|
|
58% |
19% |
6% |
17% |
77% |
- |
1) Proportion of sufficient stains
(optimal or good), 2) Proportion of sufficient stains with optimal
protocol settings only, see below.
Following central protocol parameters were used to obtain an optimal
staining:
Concentrated Abs
mAb clone PgR 636: The protocols giving an optimal result
were all based on
HIER using either Tris-EDTA/EGTA pH 9 (10/21)*, Target Retrieval Solution pH 9
(EnVision FLEX TRS high pH, Dako) (17/23), Bond Epitope Retrieval
Solution 2 (Bond, Leica) (1/3), Diva Decloaker pH6 (Biocare)(1/1),
PTM buffer pH 6 (Thermo)(1/1) or Citrate pH 6 (2/6) as the retrieval
buffer. The mAb was typically diluted in the range of 1:100– 1:600
depending on the total sensitivity of the protocol employed. Using
these protocol settings 40 out of 46 (87%) laboratories produced a
sufficient staining (optimal or good).
* (number of optimal results/number of
laboratories using this buffer)
mAb clone 16: The protocols giving an optimal result were all
based on HIER using either Tris-EDTA/EGTA pH 9 (5/6), Target Retrieval Solution pH 9 (EnVision
FLEX TRS high pH, Dako; 5/5), Bond Epitope Retrieval Solution 2
(Bond, Leica; 2/3), Cell Conditioning 1 (BenchMark, Ventana; 1/3),
Diva Decloaker pH6 (Biocare; 1/1) or Citrate pH 6 (4/5) as the
retrieval buffer. The mAb was typically diluted in the range of
1:40– 1:800 depending on the total sensitivity of the protocol
employed. Using these protocol settings 19 out of 22 (86%) laboratories produced a sufficient staining.
mAb clone cocktail 16+SAN27: The protocol giving an optimal
result was based on HIER using Bond
Epitope Retrieval Solution 1 (Bond, Leica) as the retrieval buffer.
The mAb was diluted 1:300.
rmAb clone SP2: The protocols giving an optimal result were
based on HIER using Tris-EDTA/EGTA
pH 9 (1/3) or Bond Epitope Retrieval Solution 1 (Bond, Leica; 1/1)
as the retrieval buffer. The mAb was diluted in the range of 1:50–
1:1,000 depending on the total sensitivity of the protocol employed.
Using these protocol settings 2 out of 4 laboratories
produced an optimal staining.
Ready-To-Use Abs
mAb clone PgR 636 (prod. no IR068, Dako): The
protocols giving an optimal result were all based on HIER in PT-Link
using Target Retrieval Solution pH 9 (EnVision FLEX TRS high pH), an
incubation time of 15 or 20 min in the primary Ab and EnVision Flex
(K8000) or Flex+ (K8002) as the detection system. Using these
protocol settings all of 12 (100%) laboratories produced a
sufficient staining (optimal or good).
mAb clone PgR 1294 (prod. no SK310/K1904/K4071, Dako): The
protocols giving an optimal result were based on HIER in a Pressure
Cooker using Citrate pH 6, an incubation time of 30 min in the primary
Ab and EnVision (K1904/K4071) as the detection system. Using these
protocol settings all of 3 laboratories produced a
sufficient staining.
mAb clone 16 (prod. no. PA0312, Leica): The protocol giving
an optimal result was based on HIER using Bond Epitope Retrieval
Solution 2 (Bond, Leica), an incubation time of 8 min in the primary
Ab and BOND Polymer Refine Detection (DS9800) as the detection
system.
rmAb clone 1E2 (prod. no. 790-2223/790-4296, Ventana), The
protocols giving an optimal result were based on HIER using mild or
standard Cell Conditioning 1 (1 lab used Citrate pH 6 in a MWO), an
incubation time of 16-32 min in the primary Ab and iView (760-091)
or UltraView (760-500) as the detection system. Using these protocol
settings 41 out of 44 (93%) laboratories produced a sufficient
staining (optimal or good).
- - -
The most frequent causes of insufficient stainings were:
- Too low concentration of the primary antibody
- Insufficient epitope retrieval – too short efficient HIER time
- Less successful primary antibody
- Endogenous biotin complicating the interpretation
In this assessment and in concordance with the previous PR
assessments in NordiQC, the insufficient results were mainly due to
a too weak or completely false negative staining. This pattern
was seen in 39 out of the 41 insufficient staining results (95%).
Virtually all the laboratories could demonstrate PR in the ductal
breast carcinoma no. 5 with 90-100% positivity and strong nuclear
staining intensity (as established by the NordiQC reference
laboratories) whereas the prevalent feature of the insufficient
staining was a too weak (< 10% positivity) or entirely false
negative staining of the ductal breast carcinoma no. 3 (with 40-60% positivity and a weak to moderate nuclear staining intensity
expected). The
insufficient staining reaction was typically caused by a too low concentration
of the primary Ab and/or insufficient HIER, but also when using Abs
with a presumed low PR affinity.
In 10 of the 39 stains with a too weak/false negative
staining also a false positive staining due to
endogenous biotin was seen, which especially complicated the
interpretation in the ductal breast carcinoma no. 3.
In two insufficient stains a weak but distinct false positive
nuclear staining in the PR negative ductal carcinoma no. 2 was seen.
Both protocols were based on the rmAb clone 1E2. No single parameter
causing the false positive reaction could by identified, but the
combination of efficient HIER and insufficient buffer washing may be
the reason for this pattern. A false positive nuclear
reaction was also observed and described in the previous assessment
run B6, 2008.
As also observed in previous PR assessments, the uterine cervix seems
to be an appropriate control for the evaluation of the sensitivity
of the PR staining: With an optimal protocol almost all the columnar
epithelial cells, the basal squamous epithelial cells and most of
the stromal cells must show a strong and distinct nuclear staining
with only a minimal cytoplasmic reaction. Virtually all laboratories
obtaining this staining pattern were assessed as sufficient.
However, differences regarding the reaction pattern are seen
depending on the Ab selected. When using the mAb clone 1A6, the
basal squamous epithelial cells are negative and a cytoplasmic
reaction is seen in the intermediate and superficial squamous
epithelial cells, while the clone PgR 636 gives an intense
cytoplasmic reaction in the columnar epithelial cells.
This was the fifth assessment of PR in the NordiQC breast cancer module.
A
relative constant proportion of sufficient results have been
obtained as shown in table 2.
Table 2:
Proportion of sufficient results for PR in the five NordiQC runs
performed
The availability of several robust Abs for PR seems to be the main
reason for the high pass rate. The three most commonly used clones
PgR 636, 16 and 1E2 have shown a pass rate of > 80% in the last four
PR assessments as shown in table 3:
Table 3.
Cumulated pass rate for PR in four runs
| |
Total B2, B4, B6
& B9 |
|
|
Stains submitted |
Sufficient
stains |
|
mAb clone 1A6 |
21 |
10 (48%) |
|
mAb clone 16 |
76 |
61 (80%) |
|
mAb clone PgR 636 |
205 |
163 (80%) |
|
rmAb 1E2 |
104 |
95 (91%) |
|
rmAb SP2 |
26 |
9 (35%) |
Similar results as regards the less successful clones 1A6 and SP2 have
also been puplished by UK NEQAS.2
Conclusion
The mAb clones PgR 636, 16 and the rmAb clone 1E2 are all well
performing and recommendable Abs for PR. HIER is mandatory. A
non-biotin based detection system is preferable. The concentration
of the Ab must be carefully calibrated using an appropriate control
such as the uterine cervix, in which almost all the columnar
epithelial cells, the basal squamous epithelial cells and most of
the stromal cells must show a strong and distinct nuclear staining
with only a minimal cytoplasmic reaction. |
|
|
 |
 |
|
Fig. 1a. Optimal PR staining
of the uterine cervix using the mAb clone 16. The columnar
epithelial cells and the majority of the stromal cells show a strong
nuclear staining and the basal squamous epithelial cells show a
moderate to strong nuclear staining. |
Fig. 1b. Insufficient
PR staining of the uterine cervix, using the mAb clone PgR 636
with too short HIER
time in Citrate pH 6 - same field as in Fig. 1a. The stromal cells show
a weak to moderate nuclear staining, but the basal squamous
epithelial cells are virtually negative. Also compare with Figs. 2b
& 3b – same protocol. |
 |
 |
Fig. 2a. Optimal staining
for PR of the breast ductal carcinoma no. 5 with 90 - 100% cells
positive using same protocol as in Fig. 1a.
Virtually all the neoplastic cells show a strong and distinct
nuclear staining. No background reaction is seen. |
Fig. 2b. Staining for PR
of the breast ductal carcinoma no. 5 with 90 - 100% cells positive
using same protocol as in Fig. 1b - same field as in Fig. 2a.
The majority of the neoplastic cells show a moderate and distinct
nuclear staining. However, compare with Fig. 3b - same protocol |
 |
 |
|
Fig. 3a. Optimal PR staining
of the breast ductal carcinoma no. 3 with 30 - 50% positive
cells using same protocol as in Fig. 1a & 2a.
The PR positive cells are easily recognized, as no cytoplasmic or
background reaction is seen. |
Fig. 3b. Insufficient
PR staining of the breast ductal carcinoma no. 3 with 30 - 50%
positive cells using same protocol as in Figs. 1b and 2b - same
field as in Fig. 3a.
Virtually no nuclear staining reaction is seen. |
 |
 |
|
Fig. 4a. Insufficient
PR staining of the breast ductal carcinoma no. 3 (with 30 - 50%
positive cells) using the mAb clone 16 too diluted and with HIER in
an alkaline buffer and a biotin based detection system. A strong
cytoplasmic staining due to endogenous biotin complicates the
interpretation of a weak specific nuclear staining in scattered
cells. |
Fig. 4b. Insufficient
PR staining of the breast ductal carcinoma no. 3 with 30 - 50%
positive cells.
Left: The mAb clone 1A6 used too concentrated giving an excessive
cytoplasmic staining and high level of background reaction
complicating the interpretation.
Right: The mAb clone PR-1 used with HIER in an alkaline buffer and a
3-step labelled polymer system. Despite a highly sensitive protocol
was applied, no nuclear staining reaction is seen, only an
aberrant cytoplasmic reaction is seen in the stromal cells. |
References
1. Yaziji H, Taylor CR, Goldstein NS,
Dabbs DJ, Hammond EH, Hewlett B, Floyd AD, Barry TS, Martin AW, Badve S,
Baehner F, Cartun RW, Eisen RN, Swanson PE, Hewitt SM, Vyberg M, Hicks
DG; Members of the Standardization Ad-Hoc Consensus Committee. Consensus
recommendations on estrogen receptor testing in breast cancer by
immunohistochemistry. Appl Immunohistochem Mol Morphol. 2008
Dec;16(6):513-20. PubMed PMID: 18931614.
2. Ibrahim M, Dodson A, Barnett S, Fish D, Jasani B, Miller K. Potential
for false-positive staining with a rabbit monoclonal antibody to
progesterone receptor (SP2): findings of the UK National External
Quality Assessment Scheme for Immunocytochemistry and FISH highlight the
need for correct validation of antibodies on introduction to the
laboratory. Am J Clin Pathol. 2008 Mar;129(3):398-409. PubMed PMID:
18285262. |